NCT00934648View on ClinicalTrials.gov

A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate

PHASE4CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions
Rheumatoid Arthritis
Interventions
DRUG

rituximab [MabThera/Rituxan]

1000mg iv on days 1 and 15

DRUG

methotrexate

10-25mg weekly

Trial Locations (5)

10150

Rabat

15045

Salé

20000

Casablanca

20100

Casablanca

40000

Marrakesh

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT00934648 - A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate | Biotech Hunter | Biotech Hunter